+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Subcutaneous Drug Delivery Devices Market to 2027 - Global Analysis and Forecasts by Technology; Syringe Type; Distribution Channel and Geography

  • ID: 4847177
  • Report
  • Region: Global
  • 157 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2020
1 of 3

FEATURED COMPANIES

  • Amgen
  • BD
  • Consort Medical Plc
  • Elcam Medical
  • Enable Injections
  • Insulet Corporation
  • MORE
The global subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.

The increased number of chronic disease prevalence around the globe, significant number of vaccination and immunization programs that incorporate the use of subcutaneous drug delivery devices for therapeutic administration, rise in the research and development of new products leading to the subsequent introduction of novel solutions and devices in the market are expected to account for the growth of the market. However, risk of infections and other diseases associated with the use of injections and syringes is likely to hamper the market growth.

Research and development (R&D) is an essential and crucial part of the company’s business. Pharmaceutical and medical devices companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion 2012 to US$ 58.8 billion in 2015. Also, Evonik Corporation has invested more than $50 million over the last 4 years to advance its competencies in medical devices, and production of RESOMER polymers for drug delivery and bio-reabsorbable medical devices. Thus the growing R&D expenditure drives the subcutaneous drug delivery systems market during the forecast period.

The global subcutaneous drug delivery devices market, based on the technology was segmented into syringes, pens, patches and others. In 2018, the syringes segment held the largest share of the market, by technology. However, the patches segmented is anticipated to witness fastest growth in the subcutaneous drug delivery devices market, based on technology. In the recent years, the increasing use of single-use syringes have helped to successfully reduce the rates of cross contamination thereby propelling the growth of syringes in the subcutaneous drug delivery devices market in the coming years.

Some of the major primary and secondary sources included in the report for the subcutaneous drug delivery devices Market are the World Health Organization, Organization For Economic Co-Operation And Development, Centers for Disease Control and Prevention, National Health Services, National Center for Biotechnology Information, Japan Chronic Disease Self-Management Association, Council Of Scientific And Industrial Research, and others.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the subcutaneous drug delivery devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global subcutaneous drug delivery devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen
  • BD
  • Consort Medical Plc
  • Elcam Medical
  • Enable Injections
  • Insulet Corporation
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Subcutaneous Drug Delivery Devices Market - By Technology
1.3.2 Global Subcutaneous Drug Delivery Devices Market - By Syringe Type
1.3.3 Global Subcutaneous Drug Delivery Devices Market - By Distribution Channel
1.3.4 Global Subcutaneous Drug Delivery Devices Market - By Geography

2. Global Subcutaneous Drug Delivery Devices Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Subcutaneous Drug Delivery Devices- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinions

5. Global Subcutaneous Drug Delivery Devices Market - Key Industry Dynamics
5.1.1 Increasing Incidence of Chronic Diseases
5.1.2 Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies
5.1.3 Technological Advancements and Increasing Product Launches
5.2 Key Market Restraints
5.2.1 Risks Associated with Injections:
5.3 Key Market Opportunities
5.3.1 Development of Products As Per Patient Compliance
5.4 Future Trends
5.4.1 Growing Product Innovations through Collaborative Research:
5.4.2 Rapid Adoption of Pre-Filled Saline Syringes
5.5 Impact Analysis

6. Subcutaneous Drug Delivery Devices Market - Global Analysis
6.1 Global Subcutaneous Drug Delivery Devices Market Revenue Forecasts And Analysis
6.2 Global Subcutaneous Drug Delivery Devices Market, By Geography - Forecasts And Analysis
6.3 Market Positioning of Key Players

7. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Technology
7.1 Overview
7.2 Global Subcutaneous Drug Delivery Devices Market Share by Technology 2018 & 2027 (%)
7.3 Syringes Market
7.3.1 Overview
7.3.2 Syringes Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Pens
7.3.3.1 Overview
7.3.3.2 Pens Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4 Patches
7.3.4.1 Overview
7.3.4.2 Patches Market Revenue and Forecast to 2027 (US$ Mn)
7.3.5 Others
7.3.5.1 Overview
7.3.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

8. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Syringe Type
8.1 Overview
8.2 Global Subcutaneous Drug Delivery Devices Market Share by Syringe Type 2018 & 2027 (%)
8.3 Prefilled Injectable Market
8.3.1 Overview
8.3.2 Prefilled Injectable Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Fillable Injectable Market
8.4.1 Overview
8.4.2 Fillable Injectable Market Revenue and Forecast to 2027 (US$ Mn)

9. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Distribution Channel
9.1 Overview
9.2 Global Subcutaneous Drug Delivery Devices Market Share by Distribution Channel 2018 & 2027 (%)
9.3 Hospital Pharmacies Market
9.3.1 Overview
9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Retail Pharmacies Market
9.4.1 Overview
9.4.2 Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Online Pharmacies Market
9.5.1 Overview
9.5.2 Online Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

10. Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027
10.1.1 North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.2 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.4 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.1 North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
10.4.2 US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.2.1 US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.2.2 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.2.3 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.4.2.4 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.3 Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.3.1 Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.3.2 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.3.3 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.4.3.4 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.4 Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.4.1 Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.4.2 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.4.3 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.4.4.4 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027
10.5.1 Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.6 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.7 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.1 Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
10.8.2 UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2.1 UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2.2 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.2.3 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.2.4 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.3 Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.3.1 Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.3.2 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.3.3 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.3.4 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.4 France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.4.1 France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.4.2 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.4.3 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.4.4 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.5 Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.5.1 Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.5.2 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.5.3 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.5.4 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.6 Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.6.1 Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.6.2 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.6.3 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.6.4 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027
11.1 Overview
11.2 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.3 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.5 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.6 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
11.7 Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.7.1 Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.7.1.1 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.7.1.2 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.7.1.3 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.8 China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.8.1 China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.8.1.1 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.8.1.2 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.8.1.3 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.9 India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.9.1 India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.9.1.1 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.9.1.2 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.9.1.3 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.10 Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.10.1 Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.10.1.1 Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.10.1.2 Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.10.1.3 Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.11 South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.11.1 South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.11.1.1 South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.11.1.2 South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.11.1.3 South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

12. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027
12.1 Overview
12.2 Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.3 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.4 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
12.5 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
12.6 Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
12.7 South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.7.1 South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.7.1.1 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.7.1.2 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
12.7.1.3 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
12.8 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.8.1 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.8.1.1 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.8.1.2 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
12.8.1.3 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
12.9 UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.9.1 UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.9.1.1 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.9.1.2 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
12.9.1.3 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

13. South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027
13.1 Overview
13.2 South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
13.3 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
13.4 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
13.5 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
13.6 South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
13.7 Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
13.7.1.1 Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
13.7.1.2 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
13.7.1.3 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
13.7.1.4 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
13.7.2 Argentina Subcutaneous Drug Delivery Devices Market
13.7.2.1 Argentina Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
13.7.2.2 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
13.7.2.3 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
13.7.2.4 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

14. Subcutaneous Drug Delivery Devices Market - Industry Landscape
14.1 Overview
14.2 Growth Strategies done by the companies in the Market, (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic developments
14.4.1 Overview

15. Subcutaneous Drug Delivery Devices Market - Key Company Profiles
15.1 Insulet Corporation
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Information
15.1.4 Product Portfolio
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 BD
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product Portfolio
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Amgen Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product Portfolio
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 ELCAM Medical
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product Portfolio
15.4.5 SWOT Analysis
15.4.6 Key Developments.
15.5 Ypsomed AG
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Information
15.5.4 Product Portfolio
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 West Pharmaceutical Services, Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Information
15.6.4 Product Portfolio
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Scpharmaceuticals, Inc.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 SWOT Analysis
15.7.6 Key Developments.
15.8 Wilhelm Haselmeier GmbH and Co. KG
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Overview
15.8.4 Product Portfolio
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Consort Medical PLC
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product Portfolio
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Enable Injections, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Overview
15.10.4 Product Portfolio
15.10.5 SWOT Analysis
15.10.6 Key Developments

16. Appendix
16.1 About The Publisher
16.2 Glossary Of Terms
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Insulet Corporation
  • BD
  • Enable Injections
  • Consort Medical Plc
  • West Pharmaceutical Services, Inc.
  • Elcam Medical
  • Amgen
  • Ypsomed AG
  • SCPharmaceuticals, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
Note: Product cover images may vary from those shown
Adroll
adroll